title: Treating diabetes by blocking a vascular growth factor.
abstract: Ectopic lipid deposition in muscle and liver is associated with the pathogenesis of type II diabetes. Hagberg et al. (2012) report that targeting the vascular endothelial growth factor (VEGF)-B restores insulin sensitivity and glucose tolerance by inhibiting endothelial-to-tissue lipid transport, opening promising avenues for diabetes therapy.
authors.affiliation: Department of Oncology, University of Leuven, Leuven, Belgium. peter.carmeliet@vib-kuleuven.be
authors.forename: Peter
authors.initials: P
authors.lastname: Carmeliet
authors.forename: Brian W
authors.initials: BW
authors.lastname: Wong
authors.forename: Katrien
authors.initials: K
authors.lastname: De Bock